<DOC>
	<DOCNO>NCT02273388</DOCNO>
	<brief_summary>The primary objective trial identify maximum tolerate dose ( MTD ) BI 6727 therapy term drug-related adverse event . Secondary objective collection overall safety antitumour efficacy data determination pharmacokinetic profile BI 6727 .</brief_summary>
	<brief_title>BI 6727 Administered Intravenously Every 3 Weeks Patients With Solid Tumours</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : 1 . Patients confirm diagnosis advance , non resectable / metastatic solid tumour , fail conventional treatment , therapy proven efficacy exists , amenable establish form treatment 2 . Age 18 year old 3 . Written inform consent consistent ICHGCP local legislation 4 . Eastern Cooperative Oncology Group ( ECOG , R010787 ) performance score ¿ 2 5 . Recovery CTCAE Grade 2 4 therapyrelated toxicity previous chemo , hormone , immuno , radiotherapy ( except alopecia ) The 18 additional patient recruit MTD must also meet follow criterion : 6 . Measurable tumour deposit ( RECIST ) one technique ( CT , MRI ) Exclusion criterion : 1 . Serious illness concomitant nononcological disease consider investigator incompatible protocol 2 . Pregnancy breastfeed 3 . Active infectious disease know chronic Hepatitis B/Hepatitis C infection 4 . Clinical evidence active brain leptomeningeal disease past 12 month 5 . Second malignancy currently require active therapy 6 . Absolute neutrophil count less 1500 / mm3 7 . Platelet count less 100 000 / mm3 8 . Bilirubin great 1.5 mg / dl ( &gt; 26 ¿mol / L , SI unit equivalent ) 9 . Aspartate amino transferase ( AST ) / alanine amino transferase ( ALT ) great 2.5 time upper limit normal ( related liver metastasis great five time upper limit normal ) 10 . Serum creatinine great 1.5 mg / dl ( &gt; 132 ¿mol / L , SI unit equivalent ) 11 . Known history relevant QTprolongation , e.g . long QTsyndrome 12 . Women men sexually active unwilling use medically acceptable method contraception 13 . Treatment investigational drug participation another clinical trial within past four week start therapy concomitantly trial ( except present trial drug ) 14 . Chemo , radio immunotherapy within past four week start therapy concomitantly trial . This restriction apply steroids bisphosphonates . 15 . Patients unable comply protocol 16 . Active alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>